| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |